Di Gioia and colleagues report on how the oxidized phospholipid oxPAPC alters metabolism in macrophages via glutamine and oxaloacetate, thus boosting production of the cytokine IL-1β and promoting atherosclerosis.
This is a preview of subscription content, log in via an institution to check access.
References
O’Neill, L. A., Kishton, R. J. & Rathmell, J. Nat. Rev. Immunol. 16, 553–565 (2016).
O’Neill, L. A. & Pearce, E. J. J. Exp. Med. 213, 15–23 (2016).
Hooftman, A. & O’Neill, L. A. J. Trends Immunol. 40, 687–698 (2019).
Di Gioia, M. et al Nat. Immunol. https://doi.org/10.1038/s41590-019-0539-2 (2019).
Mills, E. L. et al. Cell 167, 457–470.e13 (2016).
Bailey, J. D. et al. Cell Rep. 28, 218–230.e7 (2019).
Ridker, P. M. et al. N. Engl. J. Med. 377, 1119–1131 (2017).
Jha, A. K. et al. Immunity 42, 419–430 (2015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
O’Neill, L.A.J. Targeting macrophage immunometabolism to prevent atherosclerosis. Nat Metab 1, 1173–1174 (2019). https://doi.org/10.1038/s42255-019-0154-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s42255-019-0154-4
- Springer Nature Limited